Nurix Therapeutics, Inc.
CBL INHIBITORS AND COMPOSITIONS FOR USE IN ADOPTIVE CELL THERAPY

Abstract:

Methods and compositions using novel Cbl inhibitors for supporting engraftment of immune cells to increase the efficacy of cell-based immunotherapeutics are disclosed. Also provided are cell-based immunotherapy methods and compositions using novel Cbl inhibitors for the propagation of cells desirable for use in cell-based immunotherapies.